Pulse Therapeutics' Series B Round

Pulse Therapeutics raised a round of funding on February 06, 2014. Investors include FTL Capital.

Pulse Therapeutics has developed a medical device designed to significantly improve the conveyance of physician-selected agents, like tPA, in the emergency department (ED). By destroying clots earlier…

Articles about Pulse Therapeutics' Series B Round: